Nov 5, 2025 04:01PM

Oct 16, 2025 09:57AM

Oct 16, 2025 07:00AM

Oct 16, 2025 07:00AM

Sep 9, 2025 06:49AM

Sep 8, 2025 07:00AM

Sep 8, 2025 07:00AM Dianthus Therapeutics Announces Positive Data for Claseprubart (DNTH103) from the Phase 2 MaGic Trial in Generalized Myasthenia Gravis, Supporting Its Potential Best-In-Class Profile

Mar 5, 2025 07:02AM

Mar 5, 2025 07:00AM

Nov 11, 2024 07:51AM

Oct 4, 2024 10:10AM

Aug 8, 2024 04:01PM

Jun 12, 2024 07:00AM

Jun 12, 2024 07:00AM Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)

Feb 26, 2024 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All